Zinganell Anne, Hegen Harald, Walde Janette, Barket Robert, Berek Klaus, Auer Michael, Schmidauer Martin, Bsteh Gabriel, Kroiss Alexander Stephan, Griesmacher Andrea, Waldner Birgit, Tschoner Alexander, Berger Thomas, Deisenhammer Florian, Di Pauli Franziska
Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Department of Statistics, Faculty of Economics and Statistics, University of Innsbruck, Innsbruck, Austria.
Eur J Neurol. 2025 May;32(5):e70176. doi: 10.1111/ene.70176.
Reduced bone mass and increased osteoporosis risk are common in people with multiple sclerosis (pwMS). The aim of the study was to identify risk factors for short-term bone loss in MS.
This prospective study included 139 pwMS (ages 18-65). Baseline data included demographics, body-mass index, physical activity, smoking, menopause status, 25-hydroxy vitamin D levels, and history of glucocorticoid use. Bone mineral density (BMD) was measured at baseline and after 2 years using dual-energy X-ray absorptiometry (DXA) for the lumbar spine and hip. Disability worsening was assessed by the Expanded Disability Status Scale (EDSS). Additionally, a literature review was conducted on longitudinal data regarding BMD in MS.
Over the 2-year follow-up period, significant BMD loss was observed in the hip (baseline g/cm: median 0.898; IQR 0.808-1.014; 2-year follow-up: 0.882; 0.784-1.01; p < 0.001), but not in the lumbar spine. Overall, 101 (73.1%) experienced hip BMD loss, with a median decrease of 3.5%. Patients with disability worsening had an approximately 7-times higher risk of bone loss compared to those without disability worsening (p = 0.013). PwMS with fractures during the follow-up period had significantly lower hip BMD (0.760, 0.546-0.890 vs. 0.909, 0.828-1.015; p = 0.024), a higher EDSS score (4.4, 2.8-5.8 vs. 2.0, 1.0-4.0 vs. p = 0.026), and were older (59, 46-62 vs. 47, 37-54; p = 0.030) compared to those without fractures.
Disability worsening was identified as a risk factor for BMD loss. These findings underscore the need for active monitoring of pwMS with disability worsening to prevent bone loss and, thus, to reduce fracture risk.
骨量减少和骨质疏松风险增加在多发性硬化症患者(pwMS)中很常见。本研究的目的是确定MS患者短期骨质流失的风险因素。
这项前瞻性研究纳入了139例pwMS患者(年龄18 - 65岁)。基线数据包括人口统计学信息、体重指数、身体活动情况、吸烟状况、绝经状态、25 - 羟基维生素D水平以及糖皮质激素使用史。使用双能X线吸收法(DXA)在基线和2年后测量腰椎和髋部的骨密度(BMD)。通过扩展残疾状态量表(EDSS)评估残疾恶化情况。此外,还对关于MS患者BMD的纵向数据进行了文献综述。
在2年的随访期内,髋部观察到显著的骨密度损失(基线g/cm:中位数0.898;四分位间距0.808 - 1.014;2年随访:0.882;0.784 - 1.01;p < 0.001),但腰椎未出现。总体而言,101例(73.1%)患者出现髋部骨密度损失,中位数下降3.5%。与未出现残疾恶化的患者相比,残疾恶化的患者骨质流失风险高出约7倍(p = 0.013)。随访期间发生骨折的pwMS患者髋部骨密度显著更低(0.760,0.546 - 0.890对比0.909,0.828 - 1.015;p = 0.024),EDSS评分更高(4.4,2.8 - 5.8对比2.0,1.0 - 4.0;p = 0.026),且年龄更大(59,46 - 62对比47,37 - 54;p = 0.030)。
残疾恶化被确定为骨密度损失的一个风险因素。这些发现强调了对残疾恶化的pwMS患者进行积极监测以预防骨质流失从而降低骨折风险的必要性。